Search
for
Sort by
Research 61–90 of 258
- The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
- The Men’s Training Cup Keep Training: a masturbation aid improves intravaginal ejaculatory latency time and Erection Hardness Score in patients who are unable to delay ejaculation
- Clinical review of ejaculatory dysfunction
- Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries
- 180 The Efficacy of Amoxapine for Ejaculatory Dysfunction
- DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
- 5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Finasteride-its impact on sexual function and prostate cancer
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Common urologic diseases in older men and their treatment: how they impact fertility
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- DUTASTERIDA ORAL VERSUS FINASTERIDA ORAL NO TRATAMENTO DA ALOPECIA ANDROGENÉTICA MASCULINA: META-ANÁLISE DE EFICÁCIA E PERFIL DE EFEITOS ADVERSOS SEXUAIS
- Risk associated with the use of 5-alpha reductase inhibitors with minoxidil in treatment of male androgenetic alopecia – literature review
- (379) The Effect of 5-α Reductase Inhibitor on Male Reproductive Function
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- PD23-06 CHANGE IN SEXUAL FUNCTION IN MEN WITH LUTS/BPH ASSOCIATED WITH LONG-TERM TREATMENT WITH DOXAZOSIN, FINASTERIDE, AND COMBINED THERAPY
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Associations between semen quality and lower urinary tract symptoms in ageing male
- Outcome of Dutasteride 0.5mg in Androgenic Alopecia
- Post-Finasteride Syndrome: An Underestimated Phenomenon
- Abstracts from the current global literature: Finasteride and sexual dysfunction
- A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia
- AB40. Sexual side effects of medical treatment of BPH
- V07-10 SEMINAL VESICULOSCOPY FOR DIAGNOSIS AND MANAGEMENT OF HEMATOSPERMIA